Intramolecular Diels−Alder/1,3-Dipolar Cycloaddition Cascade of 1,3,4-Oxadiazoles
摘要:
Full details of a systematic exploration of the intramolecular [4+2]/[3+2] cycloaddition cascade of 1,3,4-oxadiazoles are disclosed in which the scope and utility of the reaction are defined.
Provided herein are compounds, pharmaceutical compositions comprising such compounds, and methods of using such compounds to treat diseases or disorders associated with HDAC1 and/or HDAC2 activity.
[EN] AMINO HETEROCYCLIC COMPOUNDS AND USES THEREOF<br/>[FR] COMPOSÉS AMINO HÉTÉROCYCLIQUES ET LEURS UTILISATIONS
申请人:NODTHERA LTD
公开号:WO2020157069A1
公开(公告)日:2020-08-06
The present disclosure relates to compounds of Formula (I): and to their pharmaceutically acceptable salts, pharmaceutical compositions, methods of use, and methods for their preparation. The compounds disclosed herein are useful for inhibiting the maturation of cytokines of the IL-1 family by inhibiting inflammasomes and may be used in the treatment of disorders in which inflammasome activity is implicated, such as inflammatory, autoinflammatory, and autoimmune diseases and cancers.
Novel inhibitors of prolyl 4-hydroxylase. 3. Inhibition by the substrate analog N-oxaloglycine and its derivatives
作者:C. Jane Cunliffe、Trevor J. Franklin、Neil J. Hales、George B. Hill
DOI:10.1021/jm00092a016
日期:1992.7
N-Oxaloglycine (3) is an alpha-ketoglutarate (1) analogue that is a competitive inhibitor of prolyl 4-hydroxylase (EC 1.14.11.2). A study of the structure-activity relationships of some other oxalo derivatives shows that substitution on the glycine moiety modulates activity stereoselectively and that if the omega-carboxylate is homologated or replaced by either acylsulfonamides or anilide, then activity is sharply reduced. This sensitivity to these changes is contrasted with the relative insensitivity of another putative alpha-ketoglutarate analogue, pyridine-2,5-dicarboxylic acid (2), and the implication is discussed that compounds of both series are unlikely to bind to prolyl hydroxylase in the same way even though both inhibit the enzyme competitively.
Identification and Optimization of RNA-Splicing Modulators as Huntingtin Protein-Lowering Agents for the Treatment of Huntington’s Disease
作者:Longbin Liu、Karine Malagu、Alan F. Haughan、Vinod Khetarpal、Andrew J. Stott、William Esmieu、Huw D. Vater、Stephen J. Webster、Amanda J. Van de Poël、Cole Clissold、Brett Cosgrove、Benjamin Sutton、Jonathan A. Spencer、Perla Breccia、Emanuela Gancia、Silvia Bonomo、Tammy Ladduwahetty、Ovadia Lazari、Hiral Patel、Helen C. Atton、Steve Clifton、Daniel M. Mota、Dario Magnani、Amy O’Neill、Marta Stebbeds、Natsuko Macabuag、Daniel Todd、Maria E. Herva、Philip Mitchell、Mijke Visser、Sara Compte Sancerni、Laure Grand Moursel、Marta da Silva、Eva Kritikou、Taneli T. Heikkinen、Tamuna Bolkvadze、Valentina Fodale、Debora Spadafora、Manuel Daldin、Alberto Bresciani、John E. Mangette、Elizabeth M. Doherty、Matthew R. Lee、Todd Herbst、Edith Monteagudo、Douglas Macdonald、Nikolay V. Plotnikov、Mark Chambers、George McAllister、Ignacio Muňoz-Sanjuan、Celia Dominguez
DOI:10.1021/acs.jmedchem.3c01173
日期:2023.9.28
Intramolecular Diels−Alder/1,3-Dipolar Cycloaddition Cascade of 1,3,4-Oxadiazoles
作者:Gregory I. Elliott、James R. Fuchs、Brian S. J. Blagg、Hayato Ishikawa、Houchao Tao、Z.-Q. Yuan、Dale L. Boger
DOI:10.1021/ja0612549
日期:2006.8.1
Full details of a systematic exploration of the intramolecular [4+2]/[3+2] cycloaddition cascade of 1,3,4-oxadiazoles are disclosed in which the scope and utility of the reaction are defined.